Lyubomir T Vassilev Selected Research

Lyubomir T Vassilev Research Topics

Disease

37	Neoplasms (Cancer) 01/2023 - 04/2002
5	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2023 - 05/2006
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 11/2005
3	Leukemia 01/2021 - 11/2005
2	Bites and Stings (Sting) 01/2023 - 01/2022
2	Sarcoma (Soft Tissue Sarcoma) 03/2013 - 05/2011
2	Polyploidy 08/2010 - 11/2008
2	Colonic Neoplasms (Colon Cancer) 03/2005 - 10/2003
1	Triple Negative Breast Neoplasms 01/2023
1	Body Weight (Weight, Body) 01/2020
1	Liposarcoma 11/2012
1	Prostatic Neoplasms (Prostate Cancer) 05/2011
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 11/2008
1	Fibrosarcoma 08/2007

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2023 - 11/2005
9	nutlin 3IBA 05/2011 - 11/2005
8	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 12/2019
6	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2022 - 12/2019
5	peposertibIBA 01/2022 - 12/2019
5	Biomarkers (Surrogate Marker)IBA 12/2019 - 10/2003
4	Phosphotransferases (Kinase)IBA 01/2023 - 01/2009
4	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2013 - 10/2003
3	UbiquitinIBA 06/2008 - 05/2003
2	AndrogensIBA 04/2013 - 05/2011
2	RG7112IBA 04/2013 - 11/2012
2	CytokinesIBA 09/2009 - 10/2003
2	RO 3306IBA 11/2008 - 11/2006
2	Cyclin-Dependent Kinase Inhibitor p27IBA 01/2005 - 05/2003
1	InterferonsIBA 01/2023
1	DNA-Activated Protein KinaseIBA 01/2022
1	Topoisomerase II InhibitorsIBA 01/2021
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2021
1	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2021
1	CPX-351IBA 01/2021
1	CalicheamicinsIBA 01/2020
1	Immunoconjugates (Immunoconjugate)IBA 01/2020
1	Gemtuzumab (Mylotarg)FDA Link 01/2020
1	A-Form DNA (A-DNA)IBA 12/2019
1	Checkpoint Kinase 2IBA 12/2019
1	RO8994IBA 08/2014
1	Peptides (Polypeptides)IBA 09/2013
1	ATSP-7041IBA 09/2013
1	Ifosfamide FDA LinkGeneric 03/2013
1	Cisplatin (Platino)FDA LinkGeneric 05/2011
1	Methotrexate (Mexate)FDA LinkGeneric 05/2011
1	Hormones (Hormone)IBA 05/2011
1	Androgen Receptors (Androgen Receptor)IBA 05/2011
1	TubulinIBA 08/2010
1	NocodazoleIBA 08/2010
1	Calcitriol (Calcijex)FDA LinkGeneric 05/2010
1	pyrimidineIBA 01/2009
1	Ligases (Synthetase)IBA 06/2008
1	LigandsIBA 04/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2008
1	Proto-Oncogene Proteins c-mdm2IBA 05/2007
1	Histone Deacetylase InhibitorsIBA 08/2005
1	trichostatin A (A 300)IBA 08/2005
1	Histone Deacetylases (Histone Deacetylase)IBA 08/2005
1	romidepsin (FK228)FDA Link 08/2005
1	Antimitotic AgentsIBA 03/2005
1	Paclitaxel (Taxol)FDA LinkGeneric 03/2005
1	Cytostatic AgentsIBA 04/2004
1	Culture MediaIBA 10/2003
1	Transforming Growth Factor beta (TGF-beta)IBA 10/2003
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 05/2003
1	Ro 41-4439IBA 04/2002
1	AcidsIBA 04/2002
1	Cytotoxins (Cytolysins)IBA 04/2002

Therapy/Procedure

30	Therapeutics 01/2023 - 10/2003
7	Drug Therapy (Chemotherapy) 01/2023 - 03/2005
5	Radiotherapy 01/2023 - 12/2019
3	Oral Administration 01/2022 - 04/2013
2	Immunotherapy 01/2023 - 01/2022
1	Radioimmunotherapy 01/2022
1	Castration 05/2011
1	Oncolytic Virotherapy 05/2007